Brian J. Blaser is the President and Chief Executive Officer of QuidelOrtho Corp, a leading in vitro diagnostics company. With a distinguished career spanning over three decades in the diagnostics industry, Blaser has demonstrated exceptional leadership and strategic vision. Prior to his role at QuidelOrtho, he served as President and CEO of Ortho Clinical Diagnostics, where he successfully led the company through a period of significant growth and innovation. Blaser's extensive experience in the field has equipped him with a deep understanding of the industry's challenges and opportunities, making him an invaluable asset to QuidelOrtho. Under Blaser's leadership, QuidelOrtho has solidified its position as a global leader in diagnostic solutions. He has been instrumental in driving the company's mission to provide healthcare professionals with innovative tools to improve patient outcomes. Blaser's strategic initiatives have focused on expanding the company's product portfolio, enhancing its global presence, and fostering a culture of excellence and collaboration. His commitment to advancing healthcare through cutting-edge diagnostics has earned him recognition within the industry and among his peers. As President and CEO, Brian J. Blaser plays a pivotal role in shaping QuidelOrtho's future. He oversees the company's overall operations, ensuring that it remains at the forefront of the diagnostics industry. Blaser's leadership style emphasizes innovation, quality, and customer satisfaction, which has been crucial in maintaining QuidelOrtho's competitive edge. His vision for the company includes continued investment in research and development, strategic partnerships, and a focus on meeting the evolving needs of healthcare providers worldwide. Through his dedication and expertise, Blaser continues to drive QuidelOrtho towards new heights of success and impact in the global healthcare landscape.